420 related articles for article (PubMed ID: 15697325)
1. Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
Raison CL; Demetrashvili M; Capuron L; Miller AH
CNS Drugs; 2005; 19(2):105-23. PubMed ID: 15697325
[TBL] [Abstract][Full Text] [Related]
2. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.
Maddock C; Baita A; Orrù MG; Sitzia R; Costa A; Muntoni E; Farci MG; Carpiniello B; Pariante CM
J Psychopharmacol; 2004 Mar; 18(1):41-6. PubMed ID: 15107183
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
Schaefer M; Mauss S
Curr Drug Abuse Rev; 2008 Jun; 1(2):177-87. PubMed ID: 19630716
[TBL] [Abstract][Full Text] [Related]
5. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
6. Modafinil's use in combating interferon-induced fatigue.
Martin KA; Krahn LE; Balan V; Rosati MJ
Dig Dis Sci; 2007 Apr; 52(4):893-6. PubMed ID: 17318387
[TBL] [Abstract][Full Text] [Related]
7. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.
Constant A; Castera L; Dantzer R; Couzigou P; de Ledinghen V; Demotes-Mainard J; Henry C
J Clin Psychiatry; 2005 Aug; 66(8):1050-7. PubMed ID: 16086622
[TBL] [Abstract][Full Text] [Related]
8. Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
McNutt MD; Liu S; Manatunga A; Royster EB; Raison CL; Woolwine BJ; Demetrashvili MF; Miller AH; Musselman DL
Neuropsychopharmacology; 2012 May; 37(6):1444-54. PubMed ID: 22353759
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Vignau J; Karila L; Costisella O; Canva V
Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
[TBL] [Abstract][Full Text] [Related]
10. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.
Dell'Osso L; Pini S; Maggi L; Rucci P; Del Debbio A; Carlini M; Baldini A; Ferrari G; Manca E; Beverini E; Amore M; Scarallo V; Semeraro Q; Brunetto M; Bonino F; Maj M
J Psychosom Res; 2007 Mar; 62(3):349-55. PubMed ID: 17324686
[TBL] [Abstract][Full Text] [Related]
11. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
12. Bupropion for treatment of interferon-induced depression.
Malek-Ahmadi P; Ghandour E
Ann Pharmacother; 2004; 38(7-8):1202-5. PubMed ID: 15150377
[TBL] [Abstract][Full Text] [Related]
13. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Capuron L; Gumnick JF; Musselman DL; Lawson DH; Reemsnyder A; Nemeroff CB; Miller AH
Neuropsychopharmacology; 2002 May; 26(5):643-52. PubMed ID: 11927189
[TBL] [Abstract][Full Text] [Related]
14. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.
Huckans M; Fuller B; Wheaton V; Jaehnert S; Ellis C; Kolessar M; Kriz D; Anderson JR; Berggren K; Olavarria H; Sasaki AW; Chang M; Flora KD; Loftis JM
J Psychosom Res; 2015 Feb; 78(2):184-92. PubMed ID: 25219976
[TBL] [Abstract][Full Text] [Related]
17. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.
Loftis JM; Patterson AL; Wilhelm CJ; McNett H; Morasco BJ; Huckans M; Morgan T; Saperstein S; Asghar A; Hauser P
J Psychosom Res; 2013 Jan; 74(1):57-63. PubMed ID: 23272989
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C.
Malaguarnera M; Laurino A; Di Fazio I; Pistone G; Castorina M; Guccione N; Rampello L
J Interferon Cytokine Res; 2001 May; 21(5):273-8. PubMed ID: 11429157
[TBL] [Abstract][Full Text] [Related]
19. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.
Asnis GM; De La Garza R
J Clin Gastroenterol; 2006 Apr; 40(4):322-35. PubMed ID: 16633105
[TBL] [Abstract][Full Text] [Related]
20. Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.
Auyeung SF; Long Q; Royster EB; Murthy S; McNutt MD; Lawson D; Miller A; Manatunga A; Musselman DL
Clin Trials; 2009 Oct; 6(5):480-90. PubMed ID: 19786415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
